BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | SVRA | 17.60M | $106.13M |
 | HTFL | 12.45M | $362.86M |
 | CABA | 9.68M | $21.19M |
 | OLMA | 8.51M | $212.72M |
 | RPID | 8.43M | $24.46M |
 | XFOR | 7.97M | $31.87M |
 | SLDB | 7.91M | $44.62M |
 | XLO | 7.37M | $4.72M |
 | NAMS | 7.31M | $256.31M |
 | CCCC | 7.17M | $13.70M |
 | ANNX | 5.25M | $26.35M |
 | KYTX | 3.11M | $29.23M |
 | PHVS | 2.80M | $77.76M |
 | AVIR | 2.49M | $8.87M |
 | UPB | 1.33M | $36.10M |
 | DNTH | 744K | $30.64M |
 | TNGX | 653K | $5.79M |
 | MRSN | 347K | $10.03M |
Savara Inc.
SVRA
Shares Held
17.60M
Value
$106.13M
Heartflow, Inc. Common Stock
HTFL
Shares Held
12.45M
Value
$362.86M
Cabaletta Bio, Inc.
CABA
Shares Held
9.68M
Value
$21.19M
Olema Pharmaceuticals, Inc.
OLMA
Shares Held
8.51M
Value
$212.72M
Rapid Micro Biosystems, Inc.
RPID
Shares Held
8.43M
Value
$24.46M
X4 Pharmaceuticals, Inc.
XFOR
Shares Held
7.97M
Value
$31.87M
Solid Biosciences Inc.
SLDB
Shares Held
7.91M
Value
$44.62M
Xilio Therapeutics, Inc.
XLO
Shares Held
7.37M
Value
$4.72M
NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
7.31M
Value
$256.31M
C4 Therapeutics, Inc.
CCCC
Shares Held
7.17M
Value
$13.70M
Annexon, Inc.
ANNX
Shares Held
5.25M
Value
$26.35M
Kyverna Therapeutics, Inc.
KYTX
Shares Held
3.11M
Value
$29.23M
Pharvaris N.V.
PHVS
Shares Held
2.80M
Value
$77.76M
Atea Pharmaceuticals, Inc.
AVIR
Shares Held
2.49M
Value
$8.87M
Upstream Bio, Inc.
UPB
Shares Held
1.33M
Value
$36.10M
Dianthus Therapeutics, Inc.
DNTH
Shares Held
744K
Value
$30.64M
Tango Therapeutics, Inc.
TNGX
Shares Held
653K
Value
$5.79M
Mersana Therapeutics, Inc.
MRSN
Shares Held
347K
Value
$10.03M